Commonwealth Equity Services
SNDX icon

Commonwealth Equity Services’s Syndax Pharmaceuticals SNDX Stock Holding History

Commonwealth Equity Services’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$228K Buy
+9,775
New +$212K ﹤0.01% 3873
2025
Q4 		– Sell
-10,906
Closed -$168K – 4434
2025
Q3 		$168K Buy
+10,906
New +$143K ﹤0.01% 3996
2023
Q4 		– Sell
-11,695
Closed -$170K – 4009
2023
Q3 		$170K Buy
11,695
+200
+2% +$3.78K ﹤0.01% 3444
2023
Q2 		$241K Buy
11,495
+605
+6% +$12.6K ﹤0.01% 3230
2023
Q1 		$230 Buy
+10,890
New +$271K ﹤0.01% 3193

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Commonwealth Equity Services's SNDX Position: Q1 2026 in Review

Commonwealth Equity Services opened a new position in Syndax Pharmaceuticals (SNDX) in Q1 2026: 9,775 shares worth $228K. The stake represents ﹤0.01% of the portfolio and ranks #3873 among its holdings. This is a return to the name: Commonwealth Equity Services previously reported a position in SNDX as recently as Q3 2025.

Commonwealth Equity Services first reported a position in SNDX in Q1 2023 and has held it in 5 quarters since. The position peaked at $241K in Q2 2023. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

  • Commonwealth Equity Services held 9,775 shares of Syndax Pharmaceuticals worth $228K as of Q1 2026.
  • Syndax Pharmaceuticals was a new Commonwealth Equity Services position in Q1 2026.
  • Syndax Pharmaceuticals made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #3873 holding.
  • Commonwealth Equity Services first reported a position in Syndax Pharmaceuticals in Q1 2023 and has held it in 5 quarters since.
  • Commonwealth Equity Services's Syndax Pharmaceuticals position peaked at $241K in Q2 2023.
  • 246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.